These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33338469)

  • 1. Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide.
    Bhattacharyya D; Bhunia A
    Chem Phys Lipids; 2021 Mar; 235():105029. PubMed ID: 33338469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut-Brain Axis: Two Ways Signaling in Parkinson's Disease.
    Dogra N; Mani RJ; Katare DP
    Cell Mol Neurobiol; 2022 Mar; 42(2):315-332. PubMed ID: 33649989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide from Gut Microbiota Modulates α-Synuclein Aggregation and Alters Its Biological Function.
    Bhattacharyya D; Mohite GM; Krishnamoorthy J; Gayen N; Mehra S; Navalkar A; Kotler SA; Ratha BN; Ghosh A; Kumar R; Garai K; Mandal AK; Maji SK; Bhunia A
    ACS Chem Neurosci; 2019 May; 10(5):2229-2236. PubMed ID: 30855940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut brain axis: an insight into microbiota role in Parkinson's disease.
    Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
    Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human gut microbiota and Parkinson's disease.
    Pant A; Bisht KS; Aggarwal S; Maiti TK
    Prog Mol Biol Transl Sci; 2022; 192(1):281-307. PubMed ID: 36280322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Endotoxin Hypothesis of Parkinson's Disease.
    Brown GC; Camacho M; Williams-Gray CH
    Mov Disord; 2023 Jul; 38(7):1143-1155. PubMed ID: 37157885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's disease.
    Dodiya HB; Forsyth CB; Voigt RM; Engen PA; Patel J; Shaikh M; Green SJ; Naqib A; Roy A; Kordower JH; Pahan K; Shannon KM; Keshavarzian A
    Neurobiol Dis; 2020 Feb; 135():104352. PubMed ID: 30579705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gut and Parkinson's Disease-A Bidirectional Pathway.
    Santos SF; de Oliveira HL; Yamada ES; Neves BC; Pereira A
    Front Neurol; 2019; 10():574. PubMed ID: 31214110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective.
    Dong S; Sun M; He C; Cheng H
    Brain Res Bull; 2022 Jun; 183():84-93. PubMed ID: 35245613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
    Rani L; Mondal AC
    Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
    Campos-Acuña J; Elgueta D; Pacheco R
    Front Immunol; 2019; 10():239. PubMed ID: 30828335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
    Rajput C; Sarkar A; Sachan N; Rawat N; Singh MP
    Neurochem Res; 2021 Mar; 46(3):425-438. PubMed ID: 33400024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
    Raj K; Singh S; Chib S; Mallan S
    Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease.
    Riegelman E; Xue KS; Wang JS; Tang L
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Gut and Nonmotor Symptoms in Parkinson's Disease.
    Klingelhoefer L; Reichmann H
    Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies.
    Perez-Pardo P; Kliest T; Dodiya HB; Broersen LM; Garssen J; Keshavarzian A; Kraneveld AD
    Eur J Pharmacol; 2017 Dec; 817():86-95. PubMed ID: 28549787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
    Sharma S; Awasthi A; Singh S
    Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.